Bioheng Therapeutics

Bioheng Therapeutics is a leading biotechnology research company dedicated to pioneering advancements in cell therapy, with a strong emphasis on allogeneic CAR-T therapies. Committed to addressing some of the most challenging unmet medical needs, Bioheng Therapeutics is focused on developing innovative and accessible solutions for patients worldwide. The company's groundbreaking work is setting new standards in the field of biotechnology.

Bioheng Therapeutics is at the forefront of developing universal CAR-T therapies, striving to create the world’s leading allogeneic cell therapy platforms and products. Bioheng Therapeutics' dedication to innovation and patient care drives its ongoing research and development efforts. With a focus on both oncology and autoimmune indications, Bioheng Therapeutics is poised to make significant contributions to the future of medicine.

Based in New Jersey, US, Bioheng Therapeutics continues to expand its research and development programs, exploring new frontiers in cell therapy and biotechnology. Bioheng Therapeutics is committed to excellence and innovation in all its endeavors, contributing to the advancement of healthcare and improved patient outcomes. We invite the manager of Bioheng Therapeutics to create a customized and exclusive company showcase and product listing on our platform.